Fred Alger Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.53M Sell
27,956
-12,800
-31% -$1.69M 0.01% 269
2026
Q1
$5.68M Buy
40,756
+16,881
+71% +$2.36M 0.02% 218
2025
Q4
$2.93M Sell
23,875
-14,094
-37% -$1.71M 0.01% 290
2025
Q3
$4.21M Sell
37,969
-25,938
-41% -$2.95M 0.02% 260
2025
Q2
$7.09M Buy
63,907
+30,724
+93% +$3.27M 0.03% 195
2025
Q1
$3.72M Buy
33,183
+3,424
+12% +$353K 0.02% 253
2024
Q4
$2.75M Buy
29,759
+2,402
+9% +$216K 0.01% 305
2024
Q3
$2.29M Hold
27,357
0.01% 316
2024
Q2
$1.88M Buy
27,357
+2,442
+10% +$163K 0.01% 323
2024
Q1
$1.83M Buy
24,915
+2,912
+13% +$224K 0.01% 349
2023
Q4
$1.78M Buy
22,003
+1,165
+6% +$90.7K 0.01% 339
2023
Q3
$1.56M Hold
20,838
0.01% 340
2023
Q2
$1.61M Hold
20,838
0.01% 353
2023
Q1
$1.73M Buy
20,838
+1,010
+5% +$83.7K 0.01% 357
2022
Q4
$1.7M Buy
19,828
+1,344
+7% +$106K 0.01% 356
2022
Q3
$1.14M Buy
18,484
+2,354
+15% +$148K 0.01% 369
2022
Q2
$997K Buy
16,130
+483
+3% +$29.9K ﹤0.01% 372
2022
Q1
$930K Buy
15,647
+1,325
+9% +$84.7K ﹤0.01% 391
2021
Q4
$1.04M Buy
14,322
+74
+0.5% +$5.1K ﹤0.01% 402
2021
Q3
$995K Hold
14,248
﹤0.01% 387
2021
Q2
$981K Hold
14,248
﹤0.01% 397
2021
Q1
$921K Sell
14,248
-203
-1% -$13.1K ﹤0.01% 393
2020
Q4
$842K Hold
14,451
﹤0.01% 383
2020
Q3
$913K Sell
14,451
-30,260
-68% -$2.1M ﹤0.01% 348
2020
Q2
$3.44M Sell
44,711
-616,737
-93% -$47.3M 0.01% 262
2020
Q1
$49.5M Buy
661,448
+646,665
+4,374% +$44.7M 0.22% 103
2019
Q4
$961K Hold
14,783
﹤0.01% 346
2019
Q3
$937K Hold
14,783
﹤0.01% 333
2019
Q2
$999K Sell
14,783
-361
-2% -$23.7K ﹤0.01% 342
2019
Q1
$985K Sell
15,144
-60,813
-80% -$4.04M ﹤0.01% 335
2018
Q4
$4.75M Buy
75,957
+24,939
+49% +$1.74M 0.02% 215
2018
Q3
$3.94M Buy
51,018
+31,989
+168% +$2.42M 0.01% 241
2018
Q2
$1.35M Buy
19,029
+2,729
+17% +$193K 0.01% 307
2018
Q1
$1.23M Sell
16,300
-12
-0.1% -$954 0.01% 322
2017
Q4
$1.17M Sell
16,312
-1,806
-10% -$137K 0.01% 322
2017
Q3
$1.47M Sell
18,118
-7,341
-29% -$561K 0.01% 303
2017
Q2
$1.8M Sell
25,459
-29,624
-54% -$1.97M 0.01% 291
2017
Q1
$3.74M Sell
55,083
-535,149
-91% -$37.6M 0.02% 247
2016
Q4
$42.3M Sell
590,232
-454,180
-43% -$33.8M 0.23% 85
2016
Q3
$82.6M Sell
1,044,412
-791,518
-43% -$64.3M 0.42% 54
2016
Q2
$153M Sell
1,835,930
-181,864
-9% -$16.1M 0.81% 28
2016
Q1
$185M Sell
2,017,794
-611,534
-23% -$55.1M 0.94% 23
2015
Q4
$266M Sell
2,629,328
-773,357
-23% -$80.5M 1.29% 17
2015
Q3
$334M Sell
3,402,685
-110,357
-3% -$12.3M 1.82% 8
2015
Q2
$411M Sell
3,513,042
-165,144
-4% -$18M 1.85% 8
2015
Q1
$361M Sell
3,678,186
-589,047
-14% -$59.8M 1.63% 8
2014
Q4
$402M Buy
4,267,233
+54,075
+1% +$5.59M 1.94% 6
2014
Q3
$896M Sell
4,213,158
-700,560
-14% -$68.6M 4.36% 2
2014
Q2
$407M Sell
4,913,718
-449,593
-8% -$35M 2.01% 4
2014
Q1
$380M Buy
5,363,311
+763,814
+17% +$59.9M 1.88% 4
2013
Q4
$345M Buy
4,599,497
+80,230
+2% +$5.59M 1.76% 5
2013
Q3
$284M Buy
4,519,267
+269,657
+6% +$16.1M 1.58% 5
2013
Q2
$218M Buy
+4,249,610
New +$222M 1.29% 8

Other funds holding GILD

Fred Alger Management's GILD Position: Q2 2026 in Review

Fred Alger Management reduced its Gilead Sciences (GILD) stake by 31% in Q2 2026, selling an estimated $1.69M and leaving 27,956 shares worth $3.53M. The position accounts for 0.01% of the portfolio, ranked #269.

Fred Alger Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $896M in Q3 2014. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fred Alger Management held 27,956 shares of Gilead Sciences worth $3.53M as of Q2 2026.
  • Fred Alger Management sold 12,800 Gilead Sciences shares in Q2 2026, an estimated $1.69M.
  • Gilead Sciences made up 0.01% of Fred Alger Management's portfolio in Q2 2026, its #269 holding.
  • Fred Alger Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Fred Alger Management's Gilead Sciences position peaked at $896M in Q3 2014.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.